These limitations are evident in the low success rates in translating promising drug treatment in SOD1 mouse models to clinical cases, despite being a widely used model because of its recapitulation of pathological and functional changes in ALS (Achilli et al. 2005). Here, SOD1 is linked to amyotrophic lateral sclerosis.